DNMT1
DNA (cytosine-5)-methyltransferase 1
Also known as: CXXC9, DNMT, DNMT1_HUMAN, MCMT
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P26358
- Gene
- DNMT1
- Ensembl
- ENSG00000130816
- Chromosome
- 19
- Canonical length
- 1616 aa
- Protein class
- Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes an enzyme that transfers methyl groups to cytosine nucleotides of genomic DNA. This protein is the major enzyme responsible for maintaining methylation patterns following DNA replication and shows a preference for hemi-methylated DNA. Methylation of DNA is an important component of mammalian epigenetic gene regulation. Aberrant methylation patterns are found in human tumors and associated with developmental abnormalities. Variation in this gene has been associated with cerebellar ataxia, deafness, and narcolepsy, and neuropathy, hereditary sensory, type IE. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
Canonical amino-acid sequenceUniProt
1616 residues, UniProt reviewed canonical sequence.
>P26358|DNMT1
1 MPARTAPARV PTLAVPAISL PDDVRRRLKD LERDSLTEKE CVKEKLNLLH EFLQTEIKNQ
61 LCDLETKLRK EELSEEGYLA KVKSLLNKDL SLENGAHAYN REVNGRLENG NQARSEARRV
121 GMADANSPPK PLSKPRTPRR SKSDGEAKPE PSPSPRITRK STRQTTITSH FAKGPAKRKP
181 QEESERAKSD ESIKEEDKDQ DEKRRRVTSR ERVARPLPAE EPERAKSGTR TEKEEERDEK
241 EEKRLRSQTK EPTPKQKLKE EPDREARAGV QADEDEDGDE KDEKKHRSQP KDLAAKRRPE
301 EKEPEKVNPQ ISDEKDEDEK EEKRRKTTPK EPTEKKMARA KTVMNSKTHP PKCIQCGQYL
361 DDPDLKYGQH PPDAVDEPQM LTNEKLSIFD ANESGFESYE ALPQHKLTCF SVYCKHGHLC
421 PIDTGLIEKN IELFFSGSAK PIYDDDPSLE GGVNGKNLGP INEWWITGFD GGEKALIGFS
481 TSFAEYILMD PSPEYAPIFG LMQEKIYISK IVVEFLQSNS DSTYEDLINK IETTVPPSGL
541 NLNRFTEDSL LRHAQFVVEQ VESYDEAGDS DEQPIFLTPC MRDLIKLAGV TLGQRRAQAR
601 RQTIRHSTRE KDRGPTKATT TKLVYQIFDT FFAEQIEKDD REDKENAFKR RRCGVCEVCQ
661 QPECGKCKAC KDMVKFGGSG RSKQACQERR CPNMAMKEAD DDEEVDDNIP EMPSPKKMHQ
721 GKKKKQNKNR ISWVGEAVKT DGKKSYYKKV CIDAETLEVG DCVSVIPDDS SKPLYLARVT
781 ALWEDSSNGQ MFHAHWFCAG TDTVLGATSD PLELFLVDEC EDMQLSYIHS KVKVIYKAPS
841 ENWAMEGGMD PESLLEGDDG KTYFYQLWYD QDYARFESPP KTQPTEDNKF KFCVSCARLA
901 EMRQKEIPRV LEQLEDLDSR VLYYSATKNG ILYRVGDGVY LPPEAFTFNI KLSSPVKRPR
961 KEPVDEDLYP EHYRKYSDYI KGSNLDAPEP YRIGRIKEIF CPKKSNGRPN ETDIKIRVNK
1021 FYRPENTHKS TPASYHADIN LLYWSDEEAV VDFKAVQGRC TVEYGEDLPE CVQVYSMGGP
1081 NRFYFLEAYN AKSKSFEDPP NHARSPGNKG KGKGKGKGKP KSQACEPSEP EIEIKLPKLR
1141 TLDVFSGCGG LSEGFHQAGI SDTLWAIEMW DPAAQAFRLN NPGSTVFTED CNILLKLVMA
1201 GETTNSRGQR LPQKGDVEML CGGPPCQGFS GMNRFNSRTY SKFKNSLVVS FLSYCDYYRP
1261 RFFLLENVRN FVSFKRSMVL KLTLRCLVRM GYQCTFGVLQ AGQYGVAQTR RRAIILAAAP
1321 GEKLPLFPEP LHVFAPRACQ LSVVVDDKKF VSNITRLSSG PFRTITVRDT MSDLPEVRNG
1381 ASALEISYNG EPQSWFQRQL RGAQYQPILR DHICKDMSAL VAARMRHIPL APGSDWRDLP
1441 NIEVRLSDGT MARKLRYTHH DRKNGRSSSG ALRGVCSCVE AGKACDPAAR QFNTLIPWCL
1501 PHTGNRHNHW AGLYGRLEWD GFFSTTVTNP EPMGKQGRVL HPEQHRVVSV RECARSQGFP
1561 DTYRLFGNIL DKHRQVGNAV PPPLAKAIGL EIKLCMLAKA RESASAKIKE EEAAKDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DNMT1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 24 nTPM
Expression across tissuesHPA
Tissue
- lymph node: 24 nTPM
- placenta: 24 nTPM
- tonsil: 23 nTPM
- bone marrow: 22 nTPM
- thymus: 19 nTPM
- appendix: 16 nTPM
Single-cell type
- cytotrophoblasts: 570 nCPM
- migrating cytotrophoblasts: 391 nCPM
- syncytiotrophoblasts: 382 nCPM
- erythrocyte progenitors: 318 nCPM
- early primary spermatocytes: 285 nCPM
- monocyte progenitors: 257 nCPM
Immune cell
- NK-cell: 43 nTPM
- plasmacytoid DC: 32 nTPM
- gdT-cell: 30 nTPM
- naive CD4 T-cell: 26 nTPM
- MAIT T-cell: 25 nTPM
- memory CD4 T-cell: 23 nTPM
Brain region
- cerebellum: 48 nTPM
- white matter: 46 nTPM
- hypothalamus: 38 nTPM
- pons: 34 nTPM
- cerebral cortex: 33 nTPM
- medulla oblongata: 32 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about DNMT1.
Disease | AllUniProt
Conditions DNMT1 is implicated in, by any mechanism.
- Neuropathy, hereditary sensory, 1E (HSN1E) MIM:614116
- Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant (ADCADN) MIM:604121
Disease | GeneticClinVar
13 pathogenic / likely-pathogenic of 1,731 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hereditary sensory neuropathy-deafness-dementia syndrome
- Autosomal dominant cerebellar ataxia, deafness and narcolepsy
- Charcot-Marie-Tooth disease
- Inborn genetic diseases
- Pituitary stalk interruption syndrome
Disease | ImmuneIEDB
Conditions an epitope on DNMT1 was assayed in.
- skin melanoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.14
- gnomAD pLI
- 1
- gnomAD missense Z
- 4.99
- DepMap mean gene effect
- -0.74
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to amino acid stimulus
- cellular response to bisphenol A
- chromosomal DNA methylation maintenance following DNA replication
- DNA methylation-dependent constitutive heterochromatin formation
- DNA-templated transcription
- methylation
- negative regulation of gene expression
- negative regulation of gene expression via chromosomal CpG island methylation
- negative regulation of transcription by RNA polymerase II
- negative regulation of vascular associated smooth muscle cell apoptotic process
- negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching
- positive regulation of gene expression
- positive regulation of vascular associated smooth muscle cell proliferation
- epigenetic programming of gene expression
Molecular functions
- DNA (cytosine-5-)-methyltransferase activity
- DNA binding
- DNA-methyltransferase activity
- lncRNA binding
- methyl-CpG binding
- promoter-specific chromatin binding
- zinc ion binding
- histone H3K14ub reader activity
- histone H3K18ub reader activity
- histone H3K23ub reader activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Bromo adjacent homology (BAH) domain
- C-5 cytosine methyltransferase
- Zinc finger, CXXC-type
- DMAP1-binding domain
- DNA methylase, C-5 cytosine-specific, active site
- S-adenosyl-L-methionine-dependent methyltransferase superfamily
- DNA methylase, C-5 cytosine-specific, conserved site
- Bromo adjacent homology (BAH) domain superfamily
- DNA Cytosine-5 Methyltransferase
- C-5 cytosine-specific DNA methylase
- BAH domain
- CXXC zinc finger domain
- DMAP1-binding Domain
- DNA (cytosine-5)-methyltransferase 1, replication foci domain
- Cytosine specific DNA methyltransferase replication foci domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DNMT1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DNMT1 as an antibody target. Whether an autoantibody or antibody against DNMT1 could matter depends on whether native DNMT1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DNMT1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DNMT1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...